Quarterly ResultAug 12, 2026, 04:11 PM
Lumexa Imaging Q2 Net Income $2.7M vs. Loss; Revenues +5.1%
AI Summary
Lumexa Imaging Holdings, Inc. reported its second quarter 2026 financial results, achieving a net income of $2.7 million, a significant improvement from a net loss of $7.2 million in the prior year. Consolidated revenues increased by 5.1% to $264.2 million. The company also announced four new imaging centers year-to-date and a joint venture with Hospital for Special Surgery (HSS). Lumexa Imaging reiterated its full-year 2026 consolidated revenue guidance and narrowed its Adjusted EBITDA guidance range.
Key Highlights
- Q2 2026 consolidated revenues increased 5.1% to $264.2 million.
- Q2 2026 net income was $2.7 million, compared to a net loss of $7.2 million in Q2 2025.
- Q2 2026 Adjusted EBITDA was $56.4 million, up from $56.3 million in Q2 2025.
- Q2 2026 GAAP EPS was $0.03 per share; Adjusted EPS was $0.20 per share.
- Announced four new imaging centers year-to-date.
- Formed a joint venture with Hospital for Special Surgery (HSS).
- Reiterated full-year 2026 consolidated revenue guidance of $1.045 billion to $1.097 billion.
- Narrowed full-year 2026 Adjusted EBITDA guidance to $235 million to $241 million.
Price Impact
More from LMRI